Results 31 to 40 of about 160,727 (166)

DeepDTAGen: a multitask deep learning framework for drug-target affinity prediction and target-aware drugs generation [PDF]

open access: yesNature Communications
Identifying novel drugs that can interact with target proteins is a highly challenging, time-consuming, and costly task in drug discovery and development. Numerous machine learning-based models have recently been utilized to accelerate the drug discovery
Pir Masoom Shah   +5 more
doaj   +2 more sources

Drug-target binding affinity prediction based on power graph and word2vec

open access: yesBMC Medical Genomics
Background Drug and protein targets affect the physiological functions and metabolic effects of the body through bonding reactions, and accurate prediction of drug-protein target interactions is crucial for drug development.
Jing Hu   +4 more
doaj   +3 more sources

MEGDTA: multi-modal drug-target affinity prediction based on protein three-dimensional structure and ensemble graph neural network [PDF]

open access: yesBMC Genomics
Background Drug development is a time-consuming and costly endeavor, and utilizing computer-aided methods to predict drug-target affinity (DTA) can significantly accelerate this process.
Zhanwei Hou   +5 more
doaj   +2 more sources

DTBind: A Mechanism-Driven Deep Learning Framework for Accurate Prediction of Drug–Target Molecular Recognition [PDF]

open access: yesResearch
Accurate prediction of drug–target molecular recognition is essential for early-stage drug discovery, spanning binding occurrence, binding site localization, and binding affinity estimation.
Qiuyu Li   +8 more
doaj   +2 more sources

Recent trends in machine learning and deep learning-based prediction of G-protein coupled receptor-ligand binding affinities [PDF]

open access: yesFrontiers in Bioinformatics
Accurately predicting protein-ligand binding affinity is key in drug discovery. Machine Learning and Deep Learning methods used in the drug discovery process have advanced the prediction of drug–target binding affinities, particularly for G protein ...
Joshua Stephenson, Konda Reddy Karnati
doaj   +2 more sources

GEFA: Early Fusion Approach in Drug-Target Affinity Prediction [PDF]

open access: yesIEEE/ACM Transactions on Computational Biology and Bioinformatics, 2022
Predicting the interaction between a compound and a target is crucial for rapid drug repurposing. Deep learning has been successfully applied in drug-target affinity (DTA) problem. However, previous deep learning-based methods ignore modeling the direct interactions between drug and protein residues.
Tri Minh Nguyen   +3 more
openaire   +3 more sources

Deep drug-target binding affinity prediction with multiple attention blocks [PDF]

open access: yesBriefings in Bioinformatics, 2021
Abstract Drug-target interaction (DTI) prediction has drawn increasing interest due to its substantial position in the drug discovery process. Many studies have introduced computational models to treat DTI prediction as a regression task, which directly predict the binding affinity of drug-target pairs.
Yuni, Zeng   +4 more
openaire   +2 more sources

Drug-Target Binding Affinity Prediction Using Transformers [PDF]

open access: yes, 2021
AbstractDrug discovery is generally difficult, expensive, and low success rate. One of the essential steps in the early stages of drug discovery and drug repurposing is identifying drug-target interactions. Binding affinity indicates the strength of drug-target pair interactions.
Mahsa Saadat   +3 more
openaire   +1 more source

GraphDTA: Predicting drug–target binding affinity with graph neural networks [PDF]

open access: yesBioinformatics, 2019
AbstractThe development of new drugs is costly, time consuming, and often accompanied with safety issues. Drug repurposing can avoid the expensive and lengthy process of drug development by finding new uses for already approved drugs. In order to repurpose drugs effectively, it is useful to know which proteins are targeted by which drugs. Computational
Thin Nguyen   +5 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy